期刊： LANCET HEALTHY LONGEVITY, 2022; 3 (7)
Background Because evidence on the safety of COVID-19 vaccines in older adults is scarce, we aimed to evaluate the incidence and risk of adverse event......
期刊： LANCET HEALTHY LONGEVITY, 2022; 3 (7)
Background The optimal treatment for older adults with diffuse large B-cell lymphoma (DLBCL) needs to be further explored due to patient comorbidities......
期刊： LANCET HEALTHY LONGEVITY, 2022; 3 (2)
Background Air pollution might accelerate cognitive ageing; it is unclear whether large-scale interventions, such as China's Clean Air Act (CCAA), can......
期刊： LANCET HEALTHY LONGEVITY, 2021; 2 (8)
Background Screening for atrial fibrillation before onset of symptoms and the subsequent initiation of oral anticoagulants could prevent stroke and de......
期刊： LANCET HEALTHY LONGEVITY, 2021; 2 (2)
COVID-19 disproportionately affects older people, with likelihood of severe complications and death mirroring that of other age-associated diseases. I......
